Dr Timothy Papaluca has completed his core gastroenterology training and is now undertaking a Hepatology Fellowship at St Vincent's Hospital, Melbourne, evaluating the novel model of care of hepatitis within a prison setting. He will also be addressing hepatitis C resistance to direct acting antivirals and efficacy of salvage regimens.

Marianne Martinello is an Infectious Diseases Physician and Viral Hepatitis Research Fellow at the Kirby Institute, UNSW Sydney and St Vincent's Hospital, Sydney.

Dr Phillip Read is a Sexual Health physician and the Director of the Kirketon Road Centre, an integrated targeted primary health facility care in Sydney's Kings Cross with a focus on prevention, treatment and care of transmissible infections including hepatitis C for people who inject drugs.

Jason Grebely is an Associate Professor in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney.

Dr Darren Russell is a sexual health physician and the Director of Sexual Health at Cairns Hospital. He holds the positions of Clinical Associate Professor in the Department of Population Health at The University of Melbourne and Adjunct Associate Professor in the School of Medicine and Dentistry at James Cook University. He is the Chair of the HIV Foundation Queensland and a past-President of the Australasian Chapter of Sexual Health Medicine of the Royal Australasian College of Physicians, the Victorian AIDS Council, and the Australian Federation of AIDS Organisations. Darren is also the Principal Investigator for the Queensland HIV prevention study – ‘QPrEPd’. His interests include Indigenous sexual health, transgender health, and the elimination of Hepatitis C infection and HIV transmissions in Australia.

Gastroenterology Advanced Trainee Cairns Hospital

Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney. He is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.